Results 1 to 10 of about 28,704 (262)

Comparative Effectiveness of Timolol-Based Fixed-Combination Regimens for Glaucoma: a Retrospective Cohort Study Using Target Trial Emulation Framework [PDF]

open access: yesOphthalmology and Therapy
Introduction Glaucoma is a leading cause of irreversible blindness, and many patients ultimately require escalation beyond monotherapy to maintain adequate intraocular pressure control.
Chin Lai   +5 more
doaj   +2 more sources

A comparative study of timolol plus either brimonidine (0.2%) or dorzolamide (2%) or latanoprost (0.005%) dual therapy in suboptimal responders to timolol (0.5%) monotherapy among patients of open-angle glaucoma, ocular hypertension and normal-tension glaucoma

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: Studies comparing the efficacy and tolerability of the three fixed combinations of timolol with its monotherapy are not readily available. In this background, the current prospective observational study was planned.
Dibyendu Chakraborty   +2 more
doaj   +1 more source

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2013
Introduction. Combining two medications in one bottle may improve compliance by reducing the time required to administer drops and the frequency of the total number of medication bottles. Objective.
Babić Nikola   +4 more
doaj   +1 more source

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma

open access: yesOftalʹmologiâ, 2014
Purpose: to study the antioxidant activity of carbonic anhydrase inhibitors and timolol fixed combinations and to compare it with other fixed combinations.Methods: Antioxidant activity (AOA) of dorzolamide/timolol (Cosopt), dorzolamide/timolol (Dorzopt ...
N. I. Kurysheva   +2 more
doaj   +3 more sources

A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [PDF]

open access: yes, 2020
Introduction. Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antago- nist, where the primary use is for glaucoma.
Aggarwal, Dipika   +10 more
core   +2 more sources

Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma [PDF]

open access: yesInternational Journal of Ophthalmology, 2014
AIM:To evaluate intraocular pressure (IOP)-lowering effect and ocular tolerability of brimonidine/timolol, dorzolamide/timolol and latanoprost/timolol fixed combination therapies in the management of primary open angle glaucoma.METHODS:Each drug was ...
Murat Atabey Ozer   +2 more
doaj   +1 more source

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. [PDF]

open access: yes, 2005
BACKGROUND: Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown.
Bosch, J   +12 more
core   +1 more source

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.

open access: yesPLoS ONE, 2012
BackgroundThe first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination medications are needed to achieve sufficiently low target IOP.
Jin-Wei Cheng   +4 more
doaj   +1 more source

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

open access: yes, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A.   +4 more
core   +1 more source

The parallel lives of polysaccharides in food and pharmaceutical formulations [PDF]

open access: yes, 2015
The present opinion article discusses how polysaccharide structures can be used in both food and pharmaceutical formulations. We distinguish two regions depending on moisture content where polysaccharides form structures with distinct functional ...
Kontogiorgos, Vassilis   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy